U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Substance Class Protein
Created
by admin
on Sat Dec 16 01:03:17 GMT 2023
Edited
by admin
on Sat Dec 16 01:03:17 GMT 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
978I8M0P8X
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BRIAKINUMAB
DASH   INN   USAN   WHO-DD  
USAN   INN  
Official Name English
ABT-874
Code English
BRIAKINUMAB [USAN]
Common Name English
BSF 415977
Code English
WAY-165772
Code English
BSF-415977
Code English
Briakinumab [WHO-DD]
Common Name English
J-695
Code English
briakinumab [INN]
Common Name English
A-796874.0
Code English
LU 415977
Code English
J695
Code English
LU-415977
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN-12 SUBUNIT BETA (IL-12 SUBUNIT P40, CLMF P40 OR NKSF2)); HUMAN MONOCLONAL .GAMMA.1 HEAVY CHAIN (218-216')-DISULFIDE WITH HUMAN MONOCLONAL .GAMMA. LIGHT CHAIN, DIMER (224-224'':227-227'')-BISDISULFIDE
Common Name English
Classification Tree Code System Code
WHO-ATC L04AC09
Created by admin on Sat Dec 16 01:03:17 GMT 2023 , Edited by admin on Sat Dec 16 01:03:17 GMT 2023
WHO-VATC QL04AC09
Created by admin on Sat Dec 16 01:03:17 GMT 2023 , Edited by admin on Sat Dec 16 01:03:17 GMT 2023
NCI_THESAURUS C20401
Created by admin on Sat Dec 16 01:03:17 GMT 2023 , Edited by admin on Sat Dec 16 01:03:17 GMT 2023
Code System Code Type Description
WIKIPEDIA
BRIAKINUMAB
Created by admin on Sat Dec 16 01:03:17 GMT 2023 , Edited by admin on Sat Dec 16 01:03:17 GMT 2023
PRIMARY
EVMPD
SUB31454
Created by admin on Sat Dec 16 01:03:17 GMT 2023 , Edited by admin on Sat Dec 16 01:03:17 GMT 2023
PRIMARY
USAN
UU-138
Created by admin on Sat Dec 16 01:03:17 GMT 2023 , Edited by admin on Sat Dec 16 01:03:17 GMT 2023
PRIMARY
FDA UNII
978I8M0P8X
Created by admin on Sat Dec 16 01:03:17 GMT 2023 , Edited by admin on Sat Dec 16 01:03:17 GMT 2023
PRIMARY
ChEMBL
CHEMBL1742995
Created by admin on Sat Dec 16 01:03:17 GMT 2023 , Edited by admin on Sat Dec 16 01:03:17 GMT 2023
PRIMARY
NCI_THESAURUS
C95321
Created by admin on Sat Dec 16 01:03:17 GMT 2023 , Edited by admin on Sat Dec 16 01:03:17 GMT 2023
PRIMARY
MESH
C544528
Created by admin on Sat Dec 16 01:03:17 GMT 2023 , Edited by admin on Sat Dec 16 01:03:17 GMT 2023
PRIMARY
DRUG BANK
DB05459
Created by admin on Sat Dec 16 01:03:17 GMT 2023 , Edited by admin on Sat Dec 16 01:03:17 GMT 2023
PRIMARY
CAS
339308-60-0
Created by admin on Sat Dec 16 01:03:17 GMT 2023 , Edited by admin on Sat Dec 16 01:03:17 GMT 2023
PRIMARY
INN
9153
Created by admin on Sat Dec 16 01:03:17 GMT 2023 , Edited by admin on Sat Dec 16 01:03:17 GMT 2023
PRIMARY
From To
1_22 1_96
1_142 1_198
1_259 1_319
1_365 1_423
2_22 2_96
2_142 2_198
2_259 2_319
2_365 2_423
3_22 3_89
3_139 3_198
4_22 4_89
4_139 4_198
1_218 3_216
2_218 4_216
1_224 2_224
1_227 2_227
Glycosylation Link Type Site
N 1_295
N 2_295
Related Record Type Details
INTERLEUKIN-12 HUMAN
TARGET -> INHIBITOR
INTERLEUKIN-23 SUBUNIT ALPHA
TARGET -> INHIBITOR
Related Record Type Details
BRIAKINUMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966